Stay updated on Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.

Latest updates to the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page
- Check3 days agoChange DetectedAdded a new revision entry v3.5.2 and removed the v3.5.0 entry from the history.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.5.0 replaces Revision: v3.4.3 in the record history.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior funding-status notice and the Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check74 days agoChange DetectedAdded a site-wide notice regarding a lapse in government funding and updated system revision to v3.4.1 (from v3.4.0).SummaryDifference0.3%

- Check81 days agoChange DetectedGlossary toggle added and color-coded diff indicators introduced. The revision tag updated to v3.4.0, and the No FEAR Act label was updated (added as 'No FEAR Act Data' and the older 'No FEAR Act data' label removed).SummaryDifference0.4%

Stay in the know with updates to Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.